Elixxer Ltd. (ELIXF)
OTCMKTS · Delayed Price · Currency is USD
0.0335
+0.0223 (199.11%)
At close: Jan 22, 2026
Elixxer Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.04 | 0.04 | 0.02 | 0.02 | 0.07 | 0.3 |
Short-Term Investments | - | - | - | - | 2.41 | 13.28 |
Cash & Short-Term Investments | 0.04 | 0.04 | 0.02 | 0.02 | 2.47 | 13.59 |
Cash Growth | 248.65% | 73.01% | 0% | -99.18% | -81.81% | 546.10% |
Other Receivables | 0.02 | - | 0.05 | 0.01 | - | 0.11 |
Receivables | 0.02 | - | 0.05 | 0.01 | 0.05 | 0.11 |
Prepaid Expenses | 0 | 0.01 | - | - | - | - |
Total Current Assets | 0.07 | 0.05 | 0.07 | 0.03 | 2.53 | 13.7 |
Long-Term Investments | 0.95 | 1.01 | 2.06 | 2.78 | 2.84 | 2.82 |
Total Assets | 1.02 | 1.06 | 2.13 | 2.81 | 5.37 | 16.84 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.22 | 1.24 | 3.31 | 1.66 | 1.83 | 0.84 |
Accrued Expenses | - | - | - | 1.09 | 1.05 | 1.07 |
Short-Term Debt | - | 0.61 | 0.59 | 0.5 | 0.46 | 6.54 |
Current Portion of Long-Term Debt | 10.54 | 9.27 | 11.33 | 9.16 | 4 | - |
Total Current Liabilities | 11.76 | 11.12 | 15.23 | 12.41 | 7.34 | 8.45 |
Long-Term Debt | - | - | - | - | 3.61 | - |
Total Liabilities | 11.76 | 11.12 | 15.23 | 12.41 | 10.95 | 8.45 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 60.37 | 53.44 | 53.44 | 53.44 | 53.44 | 53.26 |
Additional Paid-In Capital | 21.41 | 17.69 | 17.43 | 17.43 | 17.43 | 16.66 |
Retained Earnings | -92.53 | -91.85 | -87.98 | -84.51 | -80.5 | -66.33 |
Comprehensive Income & Other | 0.01 | 10.66 | 4.01 | 4.03 | 4.04 | 4.79 |
Shareholders' Equity | -10.74 | -10.05 | -13.09 | -9.6 | -5.58 | 8.38 |
Total Liabilities & Equity | 1.02 | 1.06 | 2.13 | 2.81 | 5.37 | 16.84 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 10.54 | 9.88 | 11.91 | 9.66 | 8.07 | 6.54 |
Net Cash (Debt) | -10.5 | -9.84 | -11.89 | -9.64 | -5.6 | 7.04 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.21 | -0.87 | -1.05 | -0.85 | -0.50 | 0.63 |
Filing Date Shares Outstanding | 88.77 | 95.26 | 11.34 | 11.34 | 11.34 | 10.71 |
Total Common Shares Outstanding | 88.77 | 11.34 | 11.34 | 11.34 | 11.34 | 11.13 |
Working Capital | -11.69 | -11.07 | -15.16 | -12.38 | -4.81 | 5.24 |
Book Value Per Share | -0.12 | -0.89 | -1.15 | -0.85 | -0.49 | 0.75 |
Tangible Book Value | -10.74 | -10.05 | -13.09 | -9.6 | -5.58 | 8.38 |
Tangible Book Value Per Share | -0.12 | -0.89 | -1.15 | -0.85 | -0.49 | 0.75 |